Introduction Primary sclerosing cholangitis (PSC) is a bile duct disorder characterized by
ductular reaction, hepatic inflammation, and liver fibrosis. The pathogenesis of PSC is still …

Lp-X is heterogeneous in apoE content. Lp-X is taken up in cholestatic patients by apoE-
recognizing lipoprotein receptors. Further research is warranted to fully understand the …

Background Abnormal lipid metabolism manifests as hypercholesterolemia in patients with
obstructive jaundice due to lipoprotein X (LpX). Our aim was to explore the clinical …

Cutaneous xanthomas are common cutaneous lesions that arise from localized deposits of
lipid in the dermis. 1 Their presence often represents an underlying disorder of lipid …

Background Lipoprotein X (LpX) is an abnormal lipoprotein fraction, which can be detected
in patients with severe hypercholesterolaemia and cholestatic liver disease. LpX is …

Lipoprotein X (LP-X) is an abnormal cholesterol-rich lipoprotein particle that accumulates in
patients with cholestatic liver disease and familial lecithin–cholesterol acyltransferase …

Background Lipoprotein X (LpX)-mediated extremely severe hyperlipidemia is a possible
feature detectable in children with syndromic paucity of intralobular bile ducts (Alagille …

Lipoprotein-X disease in the setting of severe cholestatic hepatobiliary autoimmune disease
- ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books Search …

Abstract Introduction Lipoprotein X (Lp‐X) is an abnormal lipoprotein found in multiple
disease conditions, including liver dysfunction and cholestasis. High Lp‐X concentrations …

Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are chronic,
immune-mediated diseases which may be associated with the presence of lipoprotein X …